Skip to main content

GSK

Stock
Health Care
Drug Manufacturers - General

Performance overview

GSK Price
Price Chart

Forward-looking statistics

Beta
0.35
Risk
26.50%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England.

Company info

SectorHealth Care
IndustryDrug Manufacturers - General
Employees70K
Market cap$84.0B

Fundamentals

Enterprise value$232.4B
Revenue$43.0B
Revenue per employee—
Profit margin10.00%
Debt to equity134.99

Security info

ExchangeNyse American
Type of shareADR
Earnings per share (EPS)$2.09
Dividend per share$1.60
Revenue per share$15.45
Avg trading volume (30 day)$182M
Avg trading volume (10 day)$190M
Put-call ratio—

Macro factor sensitivity

Growth-0.8
Credit+0.7
Liquidity+0.2
Inflation-1.9
Commodities-0.5
Interest Rates-0.9

Valuation

Dividend yield4.20%
PEG Ratio8.88
Price to sales2.45
P/E Ratio8.88
Enterprise Value to Revenue5.40
Price to book11.02

Upcoming events

Next earnings dayJuly 30, 2025
Next dividend day—
Ex. dividend dayMay 16, 2025

News

FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo

GSK stock falls as an FDA panel votes against its Blenrep combo, casting doubt on U.S. approval hopes.

Zacks Investment Research (July 18, 2025)
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks Investment Research (July 18, 2025)
GSK's Specialty Medicines Unit on a Strong Footing: Here's Why

GSK is witnessing increased sales growth of its Specialty Medicines unit, a trend expected to continue through the rest of 2025.

Zacks Investment Research (July 9, 2025)
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga (June 9, 2025)
Carat Group's Fred Hassan dives into what pharma companies to watch at 2025 ASCO Annual Meeting

Fred Hassan, Carat Group chairman, joins 'Money Movers' to discuss pharma innovation in 2025 and what companies he's watching in the sector.

CNBC Television (May 30, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free